LinkedIn Profile

Access Epistem Holdings historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:epistemholdings 245764 May 24th, 2019 12:00AM Epistem Ltd. 2.0K 52.00 Open Biotechnology May 24th, 2019 03:19PM May 24th, 2019 03:19PM Epistem Ltd. is a leading contract service provider offering innovative preclinical research services, genetic and protein biomarker testing as well as histology services to pharmaceutical, biotech and academic customers to support to drug discovery and development pipelines. We have worked with over 200 pharmaceutical and biotechnology companies at both preclinical and clinical stages. Our high level of expertise and customer focus has led to an enviable track record and impressive amount of repeat business. Our preclinical contract research services group advance drug development programs for oncology, inflammatory, dermatology, auto-immune and GI disease indications. We offer an impressive range of preclinical models in these therapeutic areas. We also provide information relating to toxicity assessments and are experts in GI tox. We also offer a broad range of cell based assays including novel stem cell assays. Our biomarker services division offers GCLP compliant genetic testing, histology, FACS analysis and protein biomarker detection. Epistem’s genetics group offer gene expression and DNA genotyping sample analysis by NGS, microarray and qPCR. We specialise in working with small starting materials (down to a single cell input) applying our proprietary low input techniques and products to support drug development programs. We are specialists in fractionating cell populations and conducting genetic analysis. We have pioneered techniques using plucked scalp hair and laser capture microdissected material to provide gene expression biomarker information to drug development programs. Epistem is committed to provide reliable and innovative services to support all phases of drug development from to preclinical projects to clinical trials. Website: www.epsitem.co.uk Open GCLP, drug development, therapeutics, oncology, contract research, gene expression, biomarkers, dermatology, mucositis, preclinical, inflammatory bowel disease, IBD, angiogenesis, histology, wound healing, radiation, molecular diagnostics, hair research/growth Open 48 Grafton Street Manchester Lancashire GB M13 9XX Epistem Holdings
private:epistemholdings 245764 Feb 17th, 2018 12:00AM Epistem Ltd. 1.7K 67.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses. The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology. The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards. The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples. Epistem Holdings
private:epistemholdings 245764 Feb 16th, 2018 12:00AM Epistem Ltd. 1.7K 67.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses. The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology. The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards. The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples. Epistem Holdings
private:epistemholdings 245764 Feb 15th, 2018 12:00AM Epistem Ltd. 1.7K 67.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses. The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology. The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards. The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples. Epistem Holdings
private:epistemholdings 245764 Feb 14th, 2018 12:00AM Epistem Ltd. 1.7K 67.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses. The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology. The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards. The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples. Epistem Holdings
private:epistemholdings 245764 Feb 13th, 2018 12:00AM Epistem Ltd. 1.7K 67.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses. The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology. The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards. The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples. Epistem Holdings
private:epistemholdings 245764 Feb 12th, 2018 12:00AM Epistem Ltd. 1.7K 67.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses. The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology. The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards. The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples. Epistem Holdings
private:epistemholdings 245764 Feb 11th, 2018 12:00AM Epistem Ltd. 1.7K 67.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses. The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology. The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards. The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples. Epistem Holdings
private:epistemholdings 245764 Feb 10th, 2018 12:00AM Epistem Ltd. 1.7K 67.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses. The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology. The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards. The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples. Epistem Holdings
private:epistemholdings 245764 Feb 9th, 2018 12:00AM Epistem Ltd. 1.7K 67.00 Open Biotechnology Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses. The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology. The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards. The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples. Epistem Holdings

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.